BNP Paribas Asset Management
RVMD icon

BNP Paribas Asset Management’s Revolution Medicines RVMD Stock Holding History

BNP Paribas Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
107,032
+534
+0.5% +$78K 0.02% 576
2026
Q1 		$10.4M Buy
106,498
+2,946
+3% +$297K 0.01% 687
2025
Q4 		$8.25M Buy
103,552
+102,276
+8,015% +$6.71M 0.01% 723
2025
Q3 		$60K Hold
1,276
– – ﹤0.01% 998
2025
Q2 		$47K Buy
+1,276
New +$49K ﹤0.01% 1166

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BNP Paribas Asset Management's RVMD Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Revolution Medicines (RVMD) stake by 0.5% in Q2 2026, buying an estimated $78K and bringing the position to 107,032 shares worth $20M. The position accounts for 0.02% of the portfolio, ranked #576.

BNP Paribas Asset Management first reported a position in RVMD in Q2 2025 and has held it in 5 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • BNP Paribas Asset Management held 107,032 shares of Revolution Medicines worth $20M as of Q2 2026.
  • BNP Paribas Asset Management bought 534 Revolution Medicines shares in Q2 2026, an estimated $78K.
  • Revolution Medicines made up 0.02% of BNP Paribas Asset Management's portfolio in Q2 2026, its #576 holding.
  • BNP Paribas Asset Management first reported a position in Revolution Medicines in Q2 2025 and has held it in 5 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.